[1]何建华,张顺琼,喻文才,等.全自动远程核素分药仪的临床应用[J].国际放射医学核医学杂志,2009,33(5):301-303.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.015]
　HE Jian-hua,ZHANG Shun-qiong,YU Wen-cai,et al.Clinical application of automatic instrument for distribution of radio nuclide through remote operation[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):301-303.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.015]
点击复制

全自动远程核素分药仪的临床应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第5期
页码:
301-303
栏目:
核医学技术和方法
出版日期:
1900-01-01

文章信息/Info

Title:
Clinical application of automatic instrument for distribution of radio nuclide through remote operation
作者:
何建华;  张顺琼;  喻文才;  曾钦文
重庆医科大学附属永川医院核医学科, 重庆 402160
Author(s):
HE Jian-hua;  ZHANG Shun-qiong;  YU Wen-cai;  ZENG Qin-wen
Department of Nuclear Medicine, Affiliated Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China
关键词:
碘化钠; 碘放射性同位素; 全自动核素分药仪
Keywords:
Sodium iodide; Iodine radioisotipos; Nuclide automatic instrument
DOI:
10.3760/cnla.j.issn.1673-4114.2009.05.015
摘要:
目的 探明全自动远程核素分药仪在临床上的实用性,以减少对操作人员的辐射损伤。方法 利用该设备分发不同体积的多管样本,以检测分药仪取样精度和核素活度,并用该仪器分药和手工分药分组治疗甲亢患者,进行对比研究,观察其治疗效果。结果 该分药仪取样的绝对误差都在0.1 ml以内,且分药过程对药物的放射性活度没有影响,仪器分药组和手工分药组治疗甲亢患者的效果没有明显的差别。结论 全自动核素分药仪分药准确、可靠,减少了对操作人员的辐射损伤。
Abstract:
Objective In this study,we explored the potential clinical application of the instrument for automatic distribution of isotopes in order to reduce the injuries to operators by radiation.Methods The accuracy of samples and activities of isotopes were determined by acquisition of the samples through the instrument distributing multiple samples at different volumes.In addition,the therapeutical effects on the patients with thyroidism were compared between those who were treated by the isotope distributed via the instrument(IDI group)and those who were treated by the isotope distributed manually(IDM group).Results Acquisition errors by the instrument were under 0.1ml and the isotope distribution didn’t affect the activity of radiation.Moreover,no significant difference was observed between the IDI group and the IDM group.Conclusion Isotope distribution by the instrument is accurate and reliable.And by this proceeding,radiation injuries to operators are decreased.

参考文献/References:

[1] 曾钦文,陈力,何建华.全自动远程核素分药仪的研制和应用.中国医药导报,2005(24):95-96.
[2] 陈勇,罗钦林,吕霞付,等.放射性同位素分装稀释系统.医疗设备信息,2004,19(5):7-8.
[3] 郭兴隆,吴文慧,罗钦林,等.一种新型同位素自动分装系统的研发.中国测试技术,2005,31(4):104-107.
[4] 肖蓉川,陈守强,宫霞霞,等.同位素液体稀释分装系统设计研发.中国辐射卫生,2008,17(2):222-225.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
　Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
　Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[3]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
　Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[4]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
　yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[5]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
　Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[6]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
　Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[7]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
　Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[8]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
　Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[9]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
　Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[10]胡小春,蒋宁一,李敬彦,等.硒对经131I治疗Graves病患者血清甲状腺过氧化物酶抗体水平的影响[J].国际放射医学核医学杂志,2015,39(2):140.[doi:10.3760/cma.j.issn.1673-4114.2015.02.008]
　Hu Xiaochun,Jiang Ningyi,Li Jingyan,et al.Effect of additional selenium on the levels of serum thyroid peroxidase antibody in patients with Graves disease treated with 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):140.[doi:10.3760/cma.j.issn.1673-4114.2015.02.008]

备注/Memo

备注/Memo:
收稿日期:2009-05-04。
通讯作者:曾钦文(E-mail:zqwen72@163.com)
更新日期/Last Update: 1900-01-01